EUCTR2006-003053-24-IT
Active, not recruiting
Not Applicable
Prophylaxis with fenoldopam in cardiac surgery patients at high risk of postoperative renal failure - ND
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI0 sites160 target enrollmentDecember 14, 2006
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cardiac surgery patients at high risk of postoperative renal failure
- Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Enrollment
- 160
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •cardiac surgery requiring cardiopulmonary bypass in patients \- high risk of postoperative renal failure \- informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\-preoperative dialysis, \- glaucoma, \- allergy to fenoldopam
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Fenoldopam and Acute Renal FailureAcute Renal FailureNCT00621790Università Vita-Salute San Raffaele667
Completed
Phase 4
Fenoldopam and Splanchnic Perfusion During Cardiopulmonary BypassCardiac ComplicationsCardiopulmonary BypassNCT00747331IRCCS Policlinico S. Donato80
Completed
Phase 3
Fenoldopam in Pediatric Cardiac SurgeryKidney Failure, AcuteNCT00982527Bambino Gesù Hospital and Research Institute80
Active, not recruiting
Not Applicable
Sevoflurane on cardiac surgery: vantage to use during CECgeneral anestetic inalathory also during CECMedDRA version: 6.1Level: PTClassification code 10018060EUCTR2005-001574-27-ITAZIENDA OSPEDALIERA DI PERUGIA
Completed
Phase 2
To study the role of febuxostat in decreasing adverse effects of free radicals in cardiac surgeryCTRI/2021/01/030807AIIMS60